J05AX Other antivirals
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 27 medicines in this group and its subgroups.
- 22 prescription only (POM)
- 2 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AX Other antivirals 27 medicines
- J05AX05 inosine pranobex 1 medicine
- J05AX07 enfuvirtide 1 medicine
- J05AX09 maraviroc 8 medicines
- J05AX10 maribavir 1 medicine
- J05AX18 letermovir 6 medicines
- J05AX23 ibalizumab 1 medicine
- J05AX24 tecovirimat 1 medicine
- J05AX25 baloxavir marboxil 3 medicines
- J05AX28 bulevirtide 1 medicine
- J05AX29 fostemsavir 1 medicine
-
J05AX Other antivirals 27 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
9 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Baloxavir marboxil 3 medicines
- Bulevirtide 1 medicine
- Cabotegravir 1 medicine
- Enfuvirtide 1 medicine
- Fostemsavir 2 medicines
- Ibalizumab 2 medicines
- Inosine acedoben dimepranol 1 medicine
- Letermovir 6 medicines
- Maraviroc 8 medicines
- Maribavir 1 medicine
- Tecovirimat 1 medicine
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Celsentri SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Celsentri 20 mg/ml oral solution SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Celsentri 300 mg film-coated tablets SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Celsentri 75 mg film-coated tablets SPC no longer supplied (J05AX09 maraviroc) | – |
| Fuzeon 90 mg / ml powder and solvent for solution for injection SPC no longer supplied (J05AX07 enfuvirtide) | – |
| Hepcludex 2 mg powder for solution for injection SPC (J05AX28 bulevirtide) | Prescription only (POM) |
| Imunovir 500 mg tablets SPC (J05AX05 inosine pranobex) | Prescription only (POM) |
| Livtencity 200 mg film-coated tablets (J05AX10 maribavir) | Prescription only (POM) |
| Maraviroc 150 mg film-coated tablets SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Maraviroc 300 mg film-coated tablets SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Maraviroc Waymade 150 mg film-coated tablets SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Maraviroc Waymade 300 mg film-coated tablets SPC (J05AX09 maraviroc) | Prescription only (POM) |
| Prevymis 120 mg granules in sachet SPC (J05AX18 letermovir) | Prescription only (POM) |
| Prevymis 20 mg granules in sachet SPC (J05AX18 letermovir) | Prescription only (POM) |
| Prevymis 240 mg concentrate for solution for infusion SPC (J05AX18 letermovir) | Prescription only (POM) |
| Prevymis 240 mg film-coated tablets SPC (J05AX18 letermovir) | Prescription only (POM) |
| Prevymis 480 mg concentrate for solution for infusion SPC (J05AX18 letermovir) | Prescription only (POM) |
| Prevymis 480 mg film-coated tablets SPC (J05AX18 letermovir) | Prescription only (POM) |
| Rukobia SPC | Prescription only (POM) |
| Rukobia 600 mg prolonged-release tablets SPC (J05AX29 fostemsavir) | Prescription only (POM) |
| Tecovirimat Siga 200 mg hard capsules SPC (J05AX24 tecovirimat) | – |
| Trogarzo SPC | – |
| Trogarzo 200 mg concentrate for solution for infusion SPC (J05AX23 ibalizumab) | – |
| Vocabria 600 mg prolonged-release suspension for injection SPC | Prescription only (POM) |
| Xofluza 2 mg/ml granules for oral suspension SPC (J05AX25 baloxavir marboxil) | Prescription only (POM) |
| Xofluza 40 mg film-coated tablets SPC (J05AX25 baloxavir marboxil) | Prescription only (POM) |
| Xofluza 80 mg film-coated tablets SPC (J05AX25 baloxavir marboxil) | Prescription only (POM) |
Other groups of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
Other names of the ATC group
- Czech: J05AX Jiná antivirotika
- French: J05AX autres antiviraux
- German: J05AX Andere antivirale Mittel
- Spanish: J05AX OTROS ANTIVIRALES (SISTEMICOS)
- German: J05AX Andere antivirale Mittel
- Italian: J05AX ALTRI ANTIVIRALI
- Polish: J05AX INNE ŚRODKI ANTYWIROTYCZNE
- Turkish: J05AX ATC'deki diğer antiviraller
- Portuguese (Brazil): J05AX Outros anti-víricos
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AX
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.